InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Piper Brian, Chief Financial Officer. Insider active across 1 companies, notably Prelude Therapeutics Inc. Cumulatively, 4 disclosures have been recorded. The latest transaction was filed on 25 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€13,3768,333 shares@ €1.60520.0037% mcap51.0% of flow
Common Stock
SEC:0001209191-21-053758·
€13,3768,333 shares@ €1.60520.0037% mcap25.5% of flow
Common Stock
SEC:0001209191-21-053758:0·
€12,8588,333 shares@ €1.5430.0036% mcap49.0% of flow
Common Stock
SEC:0001209191-21-036297·
€12,8588,333 shares@ €1.5430.0036% mcap24.5% of flow
Common Stock
SEC:0001209191-21-036297:0·
4 of 4 declarations
About Piper Brian
Brian Piper is the Chief Financial Officer at Prelude Therapeutics Inc. He is responsible for the financial management of the company, including budgeting and performance analysis. With extensive experience in finance, he plays a key role in financial strategy and decision-making. His commitment to transparency and compliance is essential for Prelude's success.
